Lynx1 Capital Management LP: PRECISION BIOSCIENCES INC (DTIL): Quarterly 13F Position History
As of Q2 2026, Lynx1 Capital Management LP reported 950,466 shares of PRECISION BIOSCIENCES INC (DTIL), worth $7.5M and representing 1.5% of its 13F equity book. Quarter-over-quarter share count change: 34,647 (-3.5%) . The position first appeared in Q4 2024 and has been disclosed across 7 13F-HR filings in Pactolio's tracked window.
- 950,466Shares Held (Latest Filing)
- $7.5MReported Market Value (Latest Filing)
- 1.5%Portfolio Weight (% of 13F Equity Book)
- 34,647Quarter-over-Quarter Share Change
- +$2.1MQuarter-over-Quarter Value Change
- 1,042,596Peak Reported Shares (Historical)
Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 7 quarter s
| Quarter | Shares | QoQ Share Change | Share Change (%) | Market Value | Weight | Implied Price |
|---|---|---|---|---|---|---|
| Q2 2026 | 950,466 | 34,647 | -3.5% | $7.5M | 1.5% | $7.9 |
| Q1 2026 | 985,113 | 8,800 | -0.9% | $5.4M | 0.9% | $5.5 |
| Q4 2025 | 993,913 | 48,683 | -4.7% | $4.1M | 0.8% | $4.2 |
| Q3 2025 | 1,042,596 | +6,545 | +0.6% | $5.8M | 1.2% | $5.5 |
| Q2 2025 | 1,036,051 | +270,000 | +35.2% | $4.4M | 1.3% | $4.2 |
| Q1 2025 | 766,051 | 0 | – | $3.7M | 1.3% | $4.8 |
| Q4 2024 | 766,051 | – | – | $2.9M | 1.1% | $3.8 |
Methodology & FAQ
How This Position History Is Sourced
Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares, a quarter-end mark rather than the manager's cost basis. See the full methodology document for the normalization rules.
When did Lynx1 Capital Management LP first disclose a DTIL position in 13F-HR filings?
Lynx1 Capital Management LP first reported PRECISION BIOSCIENCES INC (DTIL) on its 13F-HR filing for the period ending 2024-12-31 (Q4 2024). The position has appeared on 7 reported quarters within Pactolio's tracked window.
What was Lynx1 Capital Management LP's most recent quarter-over-quarter share-count change in DTIL?
Between Q1 2026 and Q2 2026, Lynx1 Capital Management LP reduced its DTIL position by 34,647 shares (-3.5%), leaving 950,466 shares at a market value of $7.5M.
Does the implied price-per-share represent Lynx1 Capital Management LP's cost basis in DTIL?
No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.